We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

68 hedge funds and large institutions have $502M invested in Loxo Oncology, Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

95% more capital invested

Capital invested by funds: $258M → $502M (+$244M)

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

33% more funds holding

Funds holding: 51 → 68 (+17)

Holders
68
Holders Change
+17
Holders Change %
+33.33%
% of All Funds
1.78%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
22
Increased
23
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$72.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$13.4M
3
AC
Aisling Capital
New York
+$9.23M
4
EAM
Eventide Asset Management
Massachusetts
+$5.75M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.56M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$22.5M
2
BI
BVF Inc
California
-$22M
3
RIM
RS Investment Management
California
-$2.81M
4
DCM
Driehaus Capital Management
Illinois
-$2.34M
5
SIM
Spark Investment Management
New York
-$939K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$306K – – –
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$298K +$281K +10,472 New
SO
53
STRS Ohio
Ohio
$293K +$276K +10,300 New
Millennium Management
54
Millennium Management
New York
$274K +$258K +9,624 New
VEA
55
Virtus ETF Advisers
New York
$263K +$248K +9,258 New
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$198K +$187K +6,971 New
NFA
57
Nationwide Fund Advisors
Ohio
$161K -$250K -9,314 -62%
Wells Fargo
58
Wells Fargo
California
$134K +$99.5K +3,709 +359%
AIG
59
American International Group
New York
$130K -$215 -8 -0.2%
Citigroup
60
Citigroup
New York
$82K +$77.1K +2,874 +287,400%
PAM
61
Panagora Asset Management
Massachusetts
$58K -$81.7K -3,045 -60%
Bank of America
62
Bank of America
North Carolina
$53K -$3.19K -119 -6%
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$49.3K +$1.74K +65 +4%
JP Morgan Chase
64
JP Morgan Chase
New York
$15K +$14.1K +524 New
AIM
65
Advantage Investment Management
Iowa
$9K – – –
GT
66
Glenmede Trust
Pennsylvania
$8K – – –
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$2K +$1.91K +71 New
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$138 – – –
BG
69
BlackRock Group
United Kingdom
– -$139K -7,924 Closed
TRCT
70
Tower Research Capital (TRC)
New York
– -$17K -953 Closed
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
– -$6K -364 Closed
UBS Group
72
UBS Group
Switzerland
– -$1K -74 Closed
Barclays
73
Barclays
United Kingdom
– -$1K -40 Closed
1 2
3

LOXO Hedge Fund Activity: Q4 2015 in Review

68 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q4 2015, worth a combined $502M — up 95% from $258M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LOXO positions and 5 closed out — a net gain of 17 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $72.6M. The largest seller was Deerfield Management, cutting an estimated $22.5M.

  • 68 institutional investors held Loxo Oncology, Inc (LOXO) as of Q4 2015, up from 51 in Q3 2015.
  • Funds reported $502M of Loxo Oncology, Inc stock for Q4 2015, up 95% quarter-over-quarter.
  • 22 funds opened new Loxo Oncology, Inc positions in Q4 2015 and 5 closed out, a net change of +17 holders.
  • The largest Loxo Oncology, Inc buyer in Q4 2015 was Fidelity Investments, an estimated $72.6M added.
  • The largest Loxo Oncology, Inc seller in Q4 2015 was Deerfield Management, an estimated $22.5M sold.

Based on aggregated 13F filings for Q4 2015.